Solventum has appointed former Zimmer Biomet executive Rachel Ellingson as chief strategy and corporate development officer.
Thermo Fisher Scientific EVP Michael Shafer sold 1,780 shares worth $945,037 under a pre-planned trading plan. He also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback